VolitionRx to Announce September Quarterly Results: Focus on Revenue Rebound and Cash Flow Turnaround
VNRX VolitionRX Ltd
$0.20 +10.41%
View chart & analysis → - 1VolitionRx has recorded a loss in value equivalent to two-thirds of its stock value following a recent update.
- 2The Street's expected September quarterly revenue of $1.2 million represents an approximately 85% year-over-year increase for VolitionRx's September quarter.
- 3Management did not provide revenue guidance and warned that revenue will occur irregularly.
So what's the key point?
VolitionRx's stock value has dropped significantly, but revenue is expected to increase by about 85% compared to last year. The key is whether revenue meets expert expectations and if cash flow improves.
Source Earnings Whispers · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.